Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2009 by Shin Kong Wu Ho-Su Memorial Hospital.
Recruitment status was:  Enrolling by invitation
Information provided by:
Shin Kong Wu Ho-Su Memorial Hospital Identifier:
First received: February 12, 2009
Last updated: March 30, 2009
Last verified: March 2009
The investigators propose that clinical pharmacist interventions would reduce the rate of adverse drug events in elderly patients taking potentially inappropriate medication.

Condition Intervention
Chronic Disease
Behavioral: Pharmacist intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Care Provider, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication: a Randomized-Controlled Trial

Further study details as provided by Shin Kong Wu Ho-Su Memorial Hospital:

Primary Outcome Measures:
  • Number of unsolved drug-related problems [ Time Frame: 14 days after randomization ]

Secondary Outcome Measures:
  • Rate of adverse drug event during hospitalization [ Time Frame: 14 days after randomization ]
  • Number of potentially inappropriate medication [ Time Frame: 14 days after randomization ]

Estimated Enrollment: 120
Study Start Date: February 2009
Estimated Study Completion Date: February 2010
Estimated Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Pharmacist intervention
Patients in the intervention group will receive pharmaceutical care delivered by clinical pharmacist, which including medication review, medication reconciliation, patient education and recommended actions.
Behavioral: Pharmacist intervention
Medication review, medication reconciliation, and pharmacotherapy recommendation.
No Intervention: Usual care
Patients randomized to usual care group will receive routine review of medication by ward-based pharmacist and nurse.


Ages Eligible for Study:   65 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Hospitalized patients aged at least 65 years
  • Taking at least six prescribed medicines regularly, including at least one potential inappropriate medication

Exclusion Criteria:

  • Patients who refused informed consent
  • Discharged before consent could be obtained
  • Cognitive impaired
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00844025

Shin Kong Wo Ho-Su Memorial Hospital, Department of Pharmacy
Taipei, Taiwan, 111
Sponsors and Collaborators
Shin Kong Wu Ho-Su Memorial Hospital
Principal Investigator: Liu Jen Wei, MS Shin Kong Wo Ho-Su Memorial Hospital
  More Information

Responsible Party: Tsai Ming Dar/Chief of Shin Kong Wu Ho-Su Memorial Hospital Research and Education Assessment Department, Shin Kong Wu Ho-Su Memorial Hospital Identifier: NCT00844025     History of Changes
Other Study ID Numbers: SKH-8302-98-NDR-05
Study First Received: February 12, 2009
Last Updated: March 30, 2009

Keywords provided by Shin Kong Wu Ho-Su Memorial Hospital:
Adverse drug reaction
Inappropriate medication
Pharmaceutical care

Additional relevant MeSH terms:
Chronic Disease
Disease Attributes
Pathologic Processes processed this record on April 25, 2017